Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima, 770-8514, Japan.
Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima, 770-8514, Japan.
Biochem Biophys Res Commun. 2022 Aug 6;616:26-32. doi: 10.1016/j.bbrc.2022.05.068. Epub 2022 May 20.
Zinc (Zn) transporter ZIP8, encoded by SLC39A8, is a unique transporter that can transport divalent manganese (Mn) and cadmium (Cd) in addition to Zn. Recently, associations between various human diseases and variant forms of ZIP8 have been reported. Four amino acid residues, V33, G38, S335, and I340, of human ZIP8 (hZIP8) are mutated in patients with congenital disorders of glycosylation (CDG), whose blood Mn levels are extremely low. Many genome-wide association studies have reported that the A391T mutation of hZIP8 caused by rs13107325 is associated with a wide range of diseases. However, the roles of individual mutations of hZIP8 on metal-transporting activity remain elusive. We established DT40 cells respectively expressing the four mutant hZIP8s and compared the Mn- and Cd-transporting activity between the mutants and wild-type hZIP8. Among the four mutations observed in the ZIP8-mutated CDG patients, the S335T and I340 N mutations in the predicted transmembrane domain 5 (TMD5) completely abolished Mn- and Cd-transporting activity, while V33 M or G35R mutations at the N-terminus did not. We also examined the A391T mutation, which slightly reduced metal transporting activity. Finally, we examined the effects of artificial mutations in the metal-binding motif EEXXH in the TMD5. Replacing EEXXH with HEXXH, which exists in most ZIP transporters, abolished the Mn- and Cd-transporting activity of hZIP8, indicating that glutamic acid in this motif plays a critical role in the unique affinity of ZIP8 for Mn and Cd. Thus, the utilization of DT40 cells enabled us to clarify the different functions of each residue of hZIP8 on metal transport.
锌(Zn)转运蛋白 ZIP8 由 SLC39A8 编码,是一种独特的转运蛋白,除了 Zn 之外,还可以转运二价锰(Mn)和镉(Cd)。最近,各种人类疾病与 ZIP8 的变体形式之间的关联已被报道。人类 ZIP8(hZIP8)中的四个氨基酸残基 V33、G38、S335 和 I340 在先天性糖基化障碍(CDG)患者中发生突变,其血液 Mn 水平极低。许多全基因组关联研究报告称,rs13107325 引起的 hZIP8 的 A391T 突变与广泛的疾病相关。然而,hZIP8 的个体突变对金属转运活性的作用仍然难以捉摸。我们分别建立了表达这四种突变 hZIP8 的 DT40 细胞,并比较了突变体与野生型 hZIP8 之间的 Mn 和 Cd 转运活性。在 ZIP8 突变型 CDG 患者中观察到的四种突变中,预测的跨膜域 5(TMD5)中的 S335T 和 I340N 突变完全消除了 Mn 和 Cd 的转运活性,而 N 端的 V33M 或 G35R 突变则没有。我们还检查了 A391T 突变,该突变略微降低了金属转运活性。最后,我们检查了 TMD5 中金属结合基序 EEXXH 中的人工突变的影响。用存在于大多数 ZIP 转运蛋白中的 HEXXH 取代 EEXXH,完全消除了 hZIP8 的 Mn 和 Cd 转运活性,表明该基序中的谷氨酸在 ZIP8 对 Mn 和 Cd 的独特亲和力中起着关键作用。因此,利用 DT40 细胞使我们能够阐明 hZIP8 上每个残基在金属转运中的不同功能。